explore -WSS

explore

author：leisure time 2025-10-08 22:54:46 - browse：68

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Cord blood banking comes at a high cost to babies

entertainment

hotspot

WSS

How to increase colonoscopy rates? Looks like an AI can help

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Wegovy trial has doctors encouraged over new possibilities

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

BMI, flaws aside, is found to be useful estimate of body fat in youth

hotspot

explore

focus

Apple is now the first public company to be valued at $3 trillion

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Moonlake's readout produced a cash windfall. Risks remain

Letters to First Opinion on caregivers, digital health, and more

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Anesthesiologist group: stop taking Ozempic before surgery

Friends ask where James Watson's attitudes about race came from

George Santos makes 1st court appearance after pleading not guilty to 13 counts

ASCO: AstraZeneca says CAR

entertainment

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

BMI, flaws aside, is found to be useful estimate of body fat in youth

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

entertainment

hotspot

hotspot

entertainment